• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨转换的胶原相关标志物反映了原发性胆汁性肝硬化患者肝纤维化的严重程度。

Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.

作者信息

Guañabens N, Parés A, Alvarez L, Martínez de Osaba M J, Monegal A, Peris P, Ballesta A M, Rodés J

机构信息

Metabolic Bone Diseases Unit, Hospital Clínic i Provincial, University of Barcelona, Spain.

出版信息

J Bone Miner Res. 1998 Apr;13(4):731-8. doi: 10.1359/jbmr.1998.13.4.731.

DOI:10.1359/jbmr.1998.13.4.731
PMID:9580479
Abstract

The influence of a nonskeletal disease with increased connective tissue synthesis or degradation in the collagen-related markers of bone turnover has been evaluated in 34 women with primary biliary cirrhosis (PBC; age range 41-81 years), a disease with increased hepatic fibrosis, often associated with osteoporosis. Serum osteocalcin (BGP), and carboxy-terminal (PICP) and amino-terminal (PINP) propeptides of type I collagen were assessed as indexes of bone formation, whereas serum tartrate-resistant acid phosphatase (TRAP), and cross-linked carboxy-terminal telopeptide of type I collagen (ICTP), and urinary hydroxyproline (HYP), pyridinoline (PYR), deoxypyridinoline (DPYR), and type I collagen cross-linked N- (NTX) and C-telopeptide (CTX) were measured as markers of bone resorption. The histologic stage of the disease and serum amino-terminal propeptide of type III collagen (PIIINP) as an index of liver fibrogenesis were also evaluated. BGP levels were significantly lower, whereas PICP and PINP levels were higher in patients than in controls. Among the bone resorption markers, serum ICTP and urinary PYR, DPYR, HYP, NTX, and CTX levels were significantly higher in patients than in controls. Serum PIIINP levels were also increased in PBC patients. BGP did not correlate with PICP and PINP, but these markers of bone formation as well as ICTP, PYR, DPYR, and NTX correlated with serum PIIINP levels. Serum TRAP did not correlate with collagen-related markers of bone resorption. Moreover, patients with PIIINP and bilirubin above normal levels had higher PICP, PINP, ICTP PYR, DPYR, CTX, and NTX. These markers correlated with the histologic stage of the disease, but not with osteopenia measured by densitometric procedures in 22 patients. In conclusion, collagen-related markers of bone turnover do not reflect bone remodeling in PBC. The close association of these markers with PIIINP and the clinical and histologic stage of the liver disease suggests that they are influenced by liver collagen metabolism.

摘要

在34名原发性胆汁性肝硬化(PBC;年龄范围41 - 81岁)女性患者中,评估了一种结缔组织合成或降解增加的非骨骼疾病对骨转换的胶原相关标志物的影响。原发性胆汁性肝硬化是一种肝纤维化增加的疾病,常伴有骨质疏松症。血清骨钙素(BGP)、I型胶原的羧基末端(PICP)和氨基末端(PINP)前肽被评估为骨形成指标,而血清抗酒石酸酸性磷酸酶(TRAP)、I型胶原交联羧基末端肽(ICTP)、尿羟脯氨酸(HYP)、吡啶啉(PYR)、脱氧吡啶啉(DPYR)以及I型胶原交联N末端(NTX)和C末端肽(CTX)被测定为骨吸收标志物。还评估了疾病的组织学分期以及血清III型胶原氨基末端前肽(PIIINP)作为肝纤维化指标。患者的BGP水平显著较低,而PICP和PINP水平高于对照组。在骨吸收标志物中,患者的血清ICTP、尿PYR、DPYR、HYP、NTX和CTX水平显著高于对照组。PBC患者的血清PIIINP水平也升高。BGP与PICP和PINP不相关,但这些骨形成标志物以及ICTP、PYR、DPYR和NTX与血清PIIINP水平相关。血清TRAP与骨吸收的胶原相关标志物不相关。此外,PIIINP和胆红素高于正常水平的患者具有更高的PICP、PINP、ICTP、PYR、DPYR、CTX和NTX。这些标志物与疾病的组织学分期相关,但与22例患者通过骨密度测量程序测得的骨质减少无关。总之,骨转换的胶原相关标志物不能反映PBC中的骨重塑。这些标志物与PIIINP以及肝病的临床和组织学分期密切相关,表明它们受肝胶原代谢的影响。

相似文献

1
Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.骨转换的胶原相关标志物反映了原发性胆汁性肝硬化患者肝纤维化的严重程度。
J Bone Miner Res. 1998 Apr;13(4):731-8. doi: 10.1359/jbmr.1998.13.4.731.
2
Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.通过新开发的骨代谢标志物预测肾性甲状旁腺功能亢进症的骨量:评估血清I型胶原羧基末端吡啶啉交联终肽和I型前胶原羧基末端前肽水平
World J Surg. 1996 Sep;20(7):753-6; discussion 756-7. doi: 10.1007/s002689900114.
3
Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.手术绝经及激素替代治疗后的骨转换生化标志物
Bone. 1999 Sep;25(3):349-53. doi: 10.1016/s8756-3282(99)00175-1.
4
Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.骨转换生化标志物在评估佩吉特病活动度中的鉴别价值。
J Bone Miner Res. 1995 Mar;10(3):458-65. doi: 10.1002/jbmr.5650100318.
5
Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity.在评估佩吉特病活动度时骨转换生化标志物与骨闪烁显像指标之间的关系。
Arthritis Rheum. 1997 Mar;40(3):461-8. doi: 10.1002/art.1780400312.
6
Biochemical markers of bone turnover in Camurati-Engelmann disease: a report on four cases in one family.卡姆拉蒂-恩格尔曼病骨转换的生化标志物:一个家族中4例病例报告
Calcif Tissue Int. 1997 Jul;61(1):48-51. doi: 10.1007/s002239900293.
7
Comparison of markers for bone formation and resorption in premenopausal and postmenopausal subjects, and osteoporosis patients.绝经前和绝经后女性以及骨质疏松症患者骨形成和骨吸收标志物的比较。
J Clin Endocrinol Metab. 1995 Aug;80(8):2447-50. doi: 10.1210/jcem.80.8.7629240.
8
Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.骨转换生化标志物对激素替代疗法的反应:生物学变异性的影响
J Bone Miner Res. 1998 Jul;13(7):1124-33. doi: 10.1359/jbmr.1998.13.7.1124.
9
Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.血清Ⅰ型前胶原羧基末端前肽和抗酒石酸酸性磷酸酶测定在评估慢性肾衰竭患者骨转换中的临床应用价值
Miner Electrolyte Metab. 1994;20(5):259-64.
10
Biochemical bone markers in patients with multiple myeloma.多发性骨髓瘤患者的生化骨标志物
Clin Chim Acta. 1996 Sep 30;253(1-2):61-77. doi: 10.1016/0009-8981(96)06334-6.

引用本文的文献

1
Hepatic osteodystrophy: An underrecognized metabolic bone disease.肝性骨营养不良:一种未被充分认识的代谢性骨病。
World J Hepatol. 2025 Aug 27;17(8):109093. doi: 10.4254/wjh.v17.i8.109093.
2
Effect of Zoledronic Acid in Hepatic Osteodystrophy: A Double-Blinded Placebo-Controlled Trial.唑来膦酸对肝性骨营养不良的影响:一项双盲安慰剂对照试验。
Indian J Endocrinol Metab. 2023 Nov-Dec;27(6):552-558. doi: 10.4103/ijem.ijem_233_23. Epub 2024 Jan 11.
3
Association of lymphocyte subsets and cytokines with bone metabolism: a retrospective, cross-sectional study.
淋巴细胞亚群和细胞因子与骨代谢的关系:一项回顾性、横断面研究。
BMC Musculoskelet Disord. 2024 Jan 9;25(1):43. doi: 10.1186/s12891-023-07137-8.
4
Bone Turnover Markers: Basic Biology to Clinical Applications.骨转换标志物:基础生物学与临床应用。
Endocr Rev. 2023 May 8;44(3):417-473. doi: 10.1210/endrev/bnac031.
5
Bone Phenotyping Approaches in Human, Mice and Zebrafish - Expert Overview of the EU Cost Action GEMSTONE ("GEnomics of MusculoSkeletal traits TranslatiOnal NEtwork").人类、小鼠和斑马鱼中的骨骼表型分析方法——EU COST 行动 GEMSTONE(“肌肉骨骼特征转化遗传学网络”)专家综述。
Front Endocrinol (Lausanne). 2021 Dec 1;12:720728. doi: 10.3389/fendo.2021.720728. eCollection 2021.
6
Determining Bone Turnover Status in Patients With Chronic Liver Disease.确定慢性肝病患者的骨转换状态
Cureus. 2021 Apr 13;13(4):e14479. doi: 10.7759/cureus.14479.
7
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases.成纤维细胞生长因子21:非酒精性脂肪性肝炎及相关代谢性疾病的新兴治疗靶点
Front Endocrinol (Lausanne). 2020 Dec 14;11:601290. doi: 10.3389/fendo.2020.601290. eCollection 2020.
8
Bone Turnover Markers and Probable Advanced Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Men and Postmenopausal Women With Type 2 Diabetes.2型糖尿病中老年男性和绝经后女性的骨转换标志物与可能的晚期非酒精性脂肪性肝病
Front Endocrinol (Lausanne). 2020 Jan 28;10:926. doi: 10.3389/fendo.2019.00926. eCollection 2019.
9
EASL Clinical Practice Guidelines on nutrition in chronic liver disease.EASL 临床实践指南:慢性肝病中的营养问题。
J Hepatol. 2019 Jan;70(1):172-193. doi: 10.1016/j.jhep.2018.06.024. Epub 2018 Aug 23.
10
A study on OPG/RANK/RANKL axis in osteoporotic bile duct-ligated rats and the involvement of nitrergic and opioidergic systems.骨质疏松性胆管结扎大鼠中OPG/RANK/RANKL轴及一氧化氮能和阿片肽能系统参与的研究
Res Pharm Sci. 2018 Jun;13(3):239-249. doi: 10.4103/1735-5362.228954.